Back to Search

MARC ROVITO, M.D.

M.D.

Hematology & Oncology Physician

NPI: 1689768319IndividualAccepts Medicare

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

MD042375L(PA)

CMS Specialties

PrimaryHEMATOLOGY/ONCOLOGY

Education

MEDICAL COLLEGE OF PENNSYLVANIA

Class of 1993

Research & Publications (3)

Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017.
PMID 18978564·J Thorac Oncol·2008
3-trial
Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes.
PMID 16797415·Exp Hematol·2006
8-other
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients.
PMID 15710576·Haematologica·2005
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
2494 BERNVILLE RD, STE G04
READING, PA 19605

Location

Practice Location

2494 BERNVILLE RD, READING, PA
(610) 378-2117

Quick Facts

NPI
1689768319
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
33
Publications
3

Are you this provider?

Claim Your Profile